-
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
(PA-16-163)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Administrative Supplements for Research on Sleep Disturbances and Impact on Chronic Pain (Admin Supp)
(PA-16-164)
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): June 24, 2016, by 5:00 PM local time of applicant organization.
-
Obesity Policy Evaluation Research (R01)
(PA-16-165)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Diet and Physical Activity Assessment Methodology (R01)
(PA-16-167)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Heart, Lung, and Blood Institute
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (R01)
(PA-16-169)
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: IDeA (Institutional Development Award) Core Optimization (Admin Supp)
(PA-16-172)
National Institute of General Medical Sciences
Application Receipt Date(s): June 7, 2016, by 5:00 PM local time of applicant organization.
-
Limited Competition: Tissue Chips for Rare Diseases (Admin Supp)
(PA-16-173)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): April 22, 2016, by 5:00 PM local time of applicant organization.
-
Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
(PA-16-175)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)
(PA-16-177)
National Cancer Institute
Application Receipt Date(s): Standard dates , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: Tissue Chips and Missing Organs (Admin Supp)
(PA-16-178)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): April 22, 2016, by 5:00 PM local time of applicant organization.
-
Integrating Biospecimen Science into Clinical Assay Development (U01)
(PAR-16-166)
National Cancer Institute
Application Receipt Date(s): June 22, 2016; February 13, 2017; October 11, 2017; June 22, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NEI Research Grant for Vision Related Secondary Data Analysis (R21)
(PAR-16-168)
National Eye Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Noise-Induced Cochlear Synaptopathy: Basic Studies Informing Potential Therapies (R01)
(PAR-16-170)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): November 3, 2016 and July 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovation for HIV Vaccine Discovery (R01)
(PAR-16-171)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 1, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Research Partnerships for Scaling Up Mental Health Interventions in Low-and Middle-Income Countries (U19)
(PAR-16-174)
National Institute of Mental Health
Application Receipt Date(s): July 15, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NCI Clinical and Translational Exploratory/Developmental Studies (R21)
(PAR-16-176)
National Cancer Institute
Application Receipt Date(s): July 19, 2016; October 18, 2016; February 21, 2017; June 19, 2017; October 17, 2017; February 20, 2018; June 19, 2018; October 17, 2018; February 20, 2019, by 5:00 PM local time of applicant organization.
-
Advancing HIV Therapeutic Vaccine Science (U01)
(RFA-AI-16-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 28, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Human Tissue Models for Infectious Diseases (U19)
(RFA-AI-16-022)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 6, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Identification of Small Molecules for Sustained-Release Anti-HIV Products (R01)
(RFA-AI-16-024)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 3, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Establishment of Resource Centers for Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24)
(RFA-DE-17-001)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 20, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Animal-Assisted Interventions for Special Populations (R03)
(RFA-HD-17-014)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 29, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Animal-Assisted Interventions for Special Populations (R21)
(RFA-HD-17-015)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 29, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21)
(RFA-MH-17-100)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 9, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R01)
(RFA-MH-17-101)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 9, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.